Principal Financial Group Inc Regenxbio Inc. Transaction History

Principal Financial Group Inc

$162 Billion
Q1 2024

A detailed history of Principal Financial Group Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 216,211 shares of RGNX stock, worth $2.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

216,211

Previous 236,023 8.39%

Holding current value

$2.3 Million

Previous $4.24 Million 7.53%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$12.17 - $24.61 $241,112 - $487,573	-19,812 Reduced 8.39%	216,211 $4.56 Million
Q4 2023 Feb 07, 2024	SELL	$12.89 - $20.82 $29,995 - $48,448	-2,327 Reduced 0.98%	236,023 $4.24 Million
Q3 2023 Nov 02, 2023	BUY	$16.46 - $19.99 $131,301 - $159,460	7,977 Added 3.46%	238,350 $3.92 Million
Q2 2023 Aug 07, 2023	SELL	$17.23 - $21.71 $200,781 - $252,986	-11,653 Reduced 4.81%	230,373 $4.61 Million
Q1 2023 May 09, 2023	SELL	$18.08 - $24.55 $90,002 - $122,209	-4,978 Reduced 2.02%	242,026 $4.58 Million

Q4 2022 Feb 09, 2023	BUY	$20.4 - $24.73 $60,669 - $73,547	2,974 Added 1.22%	247,004 $5.6 Million
Q3 2022 Nov 09, 2022	SELL	$22.29 - $35.04 $332,165 - $522,166	-14,902 Reduced 5.76%	244,030 $6.45 Million
Q2 2022 Aug 10, 2022	BUY	$19.35 - $35.04 $112,849 - $204,353	5,832 Added 2.3%	258,932 $6.4 Million
Q1 2022 May 09, 2022	SELL	$24.62 - $34.31 $59,826 - $83,373	-2,430 Reduced 0.95%	253,100 $8.4 Million
Q4 2021 Feb 09, 2022	SELL	$30.19 - $40.28 $431,928 - $576,285	-14,307 Reduced 5.3%	255,530 $8.36 Million
Q3 2021 Nov 09, 2021	BUY	$29.09 - $45.68 $395,362 - $620,836	13,591 Added 5.3%	269,837 $11.3 Million
Q2 2021 Aug 10, 2021	BUY	$32.46 - $40.48 $6,037 - $7,529	186 Added 0.07%	256,246 $9.96 Million
Q1 2021 May 10, 2021	BUY	$33.61 - $49.95 $1.14 Million - $1.69 Million	33,858 Added 15.24%	256,060 $8.73 Million
Q4 2020 Feb 08, 2021	BUY	$26.52 - $49.35 $28,190 - $52,459	1,063 Added 0.48%	222,202 $10.1 Million
Q3 2020 Nov 06, 2020	SELL	$27.01 - $40.26 $777,509 - $1.16 Million	-28,786 Reduced 11.52%	221,139 $6.09 Million
Q2 2020 Aug 05, 2020	BUY	$27.75 - $43.44 $181,235 - $283,706	6,531 Added 2.68%	249,925 $9.21 Million
Q1 2020 May 12, 2020	SELL	$21.5 - $54.2 $206,486 - $520,536	-9,604 Reduced 3.8%	243,394 $7.88 Million
Q4 2019 Feb 05, 2020	BUY	$34.54 - $44.87 $19,722 - $25,620	571 Added 0.23%	252,998 $10.4 Million
Q3 2019 Nov 13, 2019	SELL	$31.84 - $50.88 $132,613 - $211,915	-4,165 Reduced 1.62%	252,427 $8.99 Million
Q2 2019 Aug 12, 2019	BUY	$42.0 - $59.29 $37,422 - $52,827	891 Added 0.35%	256,592 $13.2 Million
Q1 2019 May 10, 2019	BUY	$40.82 - $62.45 $248,022 - $379,446	6,076 Added 2.43%	255,701 $14.7 Million
Q4 2018 Feb 14, 2019	BUY	$39.11 - $75.15 $83,069 - $159,618	2,124 Added 0.86%	249,625 $10.5 Million
Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $1.93 Million - $2.44 Million	29,671 Added 13.62%	247,501 $18.7 Million
Q2 2018 Aug 13, 2018	BUY	$27.2 - $74.35 $5.92 Million - $16.2 Million	217,830 New	217,830 $0

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

42.1M

Call Options Held

80.6K

Put Options Held

55.2K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $460M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Regenxbio Inc. Transaction History